CalciMedica (CALC) Stock Statistics & Valuation Metrics

CalciMedica has a market cap or net worth of $11.45M. The enterprise value is $8.66M.

CalciMedica has 15,743,916 shares outstanding. The number of shares has decreased by -2.65% in one year.

CalciMedica’s return on equity (ROE) is 4.45 and return on invested capital (ROIC) is -209.07%.

The current PE Ratio of CalciMedica is ―. CalciMedica’s PEG ratio is -54.43.

In the last 12 months, CalciMedica had revenue of 0.00 and earned -29.56M in profits. Earnings per share was -1.97.

In the last 12 months, operating cash flow was -21.18M and capital expenditures -28.00K, giving a free cash flow of -21.21M billion.

CalciMedica pays an annual dividend of ―, resulting in a dividend yield of ―

CalciMedica upcoming earnings date is May 18, 2026, After Close (Confirmed).

CalciMedica as a current ratio of 3.58, with Debt / Equity ratio of -146.06%

In the past 12 months, CalciMedica has paid 0.00 in taxes.

CalciMedica EV to EBITDA ratio is -4.28K, with an EV/FCF ratio of -4.66K.

CalciMedica has $13.02M in cash and marketable securities with $9.70M in debt, giving a net cash position of $3.32M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for CalciMedica is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy